sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

North America Late Stage Chronic Kidney Disease Drugs Market Scope And Analysis

  • Report Code : TIPRE00018220
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 108
Buy Now

North America Late Stage Chronic Kidney Disease Drugs Market Analysis, Size, and Growth (2020-2027)

Buy Now

North America Late Stage Chronic Kidney Disease Drugs Market Report North America Late Stage Chronic Kidney Disease Drugs Market Size and Share North America Late Stage Chronic Kidney Disease Drugs Market Scope and Analysis

North America Late Stage Chronic Kidney Disease Drugs Market Report Scope

Report Attribute Details
Market size in 2019 US$ 2,036.47 Million
Market Size by 2027 US$ 4,904.81 Million
Global CAGR (2020 - 2027) 11.8%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product Type
  • Calcimimetics
  • Vitamin D
  • Sterols
  • Potassium Binders
  • Calcium-Based Phosphate Binders
By Indication
  • Late Stage Chronic Kidney Disease Induced Hyperparathyroidism
  • Late Stage Chronic Kidney Disease Induced Hyperphosphatemia
  • Late Stage Chronic Kidney Disease Induced Hyperkalaemia
By Distribution Channel
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • AbbVie Inc
  • Amgen
  • AstraZeneca
  • Sanofi
  • Kyowa Kirin Co Ltd
  • Takeda Pharmaceutical Company Limited
  • Astellas Pharma Inc
  • Bayer AG
  • Vifor Pharma Management Ltd